Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
149 participants
INTERVENTIONAL
2020-09-07
2023-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Data consists of questionnaires of patients, their family caregivers, general practitioners, home care nurses and if involved specialized palliative home care nurses. Patients and their family caregivers will fill out baseline questionnaires and follow-up questionnaires at 2, 8, 16 and 24 weeks. Patient follow-up will end if the patient dies or the study ends. Family caregivers will be asked to fill out a questionnaire two months after the patient's death.
General practitioners, home care nurses and specialised palliative home care nurses will fill out questionnaires after the patient's death or at the end of the study. Patient survival data will be collected from administrative health data after the end of the study.
Additionally, a nested qualitative study with semi-structured qualitative interviews with patients, family caregivers and care providers will provide an in-depth understanding of preferences, needs, experiences from this phase of life.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
Patients without a new indication for specialized palliative home care are controls .
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1: Structured specialized palliative home care
Eligible specialist palliative home care teams provide ambulant specialised palliative care as usual
Specialized palliative home care
Specialist palliative home care teams will initiate care as usual, including managing a systematic and collaborative process of advance care planning with patients, family caregivers, GPs and SPITEX nurses using the "Betreuungsplan", information packages and regular case meetings. The GP was additionally provided with educational palliative care information by the study team.
Arm 2: No care of specialist palliative home care teams at study inclusion
No care from specialist palliative home care teams at study inclusion
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Specialized palliative home care
Specialist palliative home care teams will initiate care as usual, including managing a systematic and collaborative process of advance care planning with patients, family caregivers, GPs and SPITEX nurses using the "Betreuungsplan", information packages and regular case meetings. The GP was additionally provided with educational palliative care information by the study team.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to read and understand German
* Able to fill out questionnaires with only minimal assistance
* Live in the catchment area of SPHC
* Positive screening on the palliative care screening tools
* Expected survival time of approximately six months or less
* Have a GP (or GP medical substitute)
* Registered with Spitex care
* Wish to live at home as long as possible (no plans for long term nursing home uptake)
* Written informed consent
* 18 years or older
* Able to read and understand German
* Familiar with the care situation patient
* Written informed consent
Specialized palliative home care team:
* Provide care in German speaking part of canton Bern
* 24/7-availability of specialized palliative care
* Specialized palliative care team including nurses and consulting physician with specialized palliative care certification.
Exclusion Criteria
* Live permanently in nursing homes
* Cognitive impairments that make it impossible to follow the study (e.g. psychological disorders, dementia, loss of judgement).
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swiss National Science Foundation
OTHER
University of Bern
OTHER
Insel Gruppe AG, University Hospital Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Steffen Eychmüller
Prof. dr. med.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Steffen Eychmüller, Prof. dr.
Role: PRINCIPAL_INVESTIGATOR
Insel Gruppe AG, University Hospital Bern
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Inselspital Bern
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SNCTP000003820
Identifier Type: REGISTRY
Identifier Source: secondary_id
DFL Nr. 4887
Identifier Type: -
Identifier Source: org_study_id